Convergence Pharmaceuticals

About:

Convergence Pharmaceuticals is a biotechnology company focused on the development of novel analgesics for the treatment of chronic pain.

Website: http://www.convergencepharma.com

Top Investors: SV Health Investors, New Leaf Venture Partners, Apposite Capital

Description:

Convergence Pharmaceuticals is an independent biotechnology company focused on the development of novel analgesics with potentially commercially attractive efficacy, responder-rate and side effect profiles. The Company was formed in October 2010 following the acquisition of certain neuroscience clinical assets from GlaxoSmithKline (“GSK”). Convergence Pharmaceuticals has a pipeline of differentiated clinical-stage compounds targeting the points of convergence in chronic pain signaling through modulation of specific ion-channels.